Initiation of Phase 1b Study of GT-02287 in Parkinson's patients expected by end of 2024 BETHESDA, Md., Nov. 14, 2024 (GLOBE ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Human induced pluripotent stem cells (iPSCs) have a great potential for scientific and medical applications. They are used in ...

Genetic Variations May Predispose People to Parkinson's Disease Following Long-Term Pesticide ... of over 50-year-olds were found to have tissue markers ... Mar. 14, 2024 — Researchers uncovered ...

Another interesting finding from the study was that 30% of participants with the LRRK2 gene mutation – which causes a disease with Parkinson-like symptoms – did not have misfolded alpha ...

The fruit drink is rich in healthy plant compounds called polyphenols that lower blood pressure and cholesterol - protecting ...

Tel Aviv University researchers have made a discovery that could enhance our understanding of genetic mutations and their ...

Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...

The researchers: "We found that a variant of the TMEM16F protein, caused by a genetic mutation, enhances the spread of ...

Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance ...

Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial. Shares in the Anglo-US biotech rose sharply ...

A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.